Epigenos Biosciences
Greenville
About Epigenos Biosciences
Epigenos Biosciences is working on dCas9 Chemical Epigenetic Modifiers (CEM)-based cancer and rare disease therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $70.0K
- Last round: Grant (Sep 2022)
- Website: epigenos.com
Industries & Categories
Chemical, Therapeutics
Canonical: https://fsome.com/organization/epigenos-biosciences-161613 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.